BPC-157 and gastric cytoprotection: a literature review
BPC-157 is a synthetic pentadecapeptide, a 15-amino-acid sequence derived from a protein found in human gastric juice. Researchers study it for one property above all: cytoprotection, the ability to shield and repair tissue. Nearly all of that evidence comes from animal and in-vitro models, and that framing shapes how you read any claim about it.
The proposed mechanism
The most cited pathway is angiogenic. In preclinical work, BPC-157 promotes the growth of new blood vessels by upregulating vascular endothelial growth factor receptor-2 (VEGFR2) and the downstream Akt, eNOS, and nitric oxide cascade. New vasculature brings oxygen and nutrients to injured tissue, which is the leading explanation for the repair effects seen in these models.
Beyond angiogenesis, studies describe effects on the nitric oxide system, on growth-hormone receptor expression in tendon-derived cells, and on the gut-brain axis. A 2025 narrative review in the pharmacology literature pulled these threads together while flagging how much remains unproven.
What the models show
Rodent studies report faster healing across several tissue types: gastric and intestinal lining, tendon, muscle, and bone. In-vitro work on fibroblasts describes increased migration, a step in wound closure. The gastric-protection studies are the oldest strand and the reason the peptide carries the "body protection compound" name.
Two cautions belong next to every one of those findings. First, angiogenesis is not uniformly beneficial; the same reviews that credit BPC-157 with tissue repair note that promoting new vessels carries theoretical risks. Second, human clinical data is absent. A result in a mouse tendon is a hypothesis about biology, not a conclusion about people.
Why purity matters here
BPC-157 is a short peptide, which makes it a common target for low-grade synthesis. A sequence that is truncated or contaminated will not behave like the molecule in the literature, and your experiment inherits that error. Every Veristas batch of BPC-157 is verified by HPLC and mass spectrometry with a public Certificate of Analysis, so identity and purity are documented before the vial reaches the bench.
Supplied lyophilized; see the reconstitution guide for solvent and storage handling.
For in-vitro laboratory research only. Not for human or animal consumption. This literature summary is educational and makes no claim about safety or efficacy in humans.
References: McGuire et al., "Regeneration or Risk? A Narrative Review of BPC-157" (2025); Jozwiak et al., "Multifunctionality and Possible Medical Application of BPC-157" (Pharmaceuticals, 2025).